摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-dihydro-2,2,4-trimethyl-7-(1,1,1-trimethylacetoxy)quinoline | 179897-97-3

中文名称
——
中文别名
——
英文名称
1,2-dihydro-2,2,4-trimethyl-7-(1,1,1-trimethylacetoxy)quinoline
英文别名
(2,2,4-trimethyl-1H-quinolin-7-yl) 2,2-dimethylpropanoate
1,2-dihydro-2,2,4-trimethyl-7-(1,1,1-trimethylacetoxy)quinoline化学式
CAS
179897-97-3
化学式
C17H23NO2
mdl
——
分子量
273.375
InChiKey
WQUQOXZETXJWFG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,2-dihydro-2,2,4-trimethyl-7-(1,1,1-trimethylacetoxy)quinolinepalladium-carbon H2 作用下, 以 二氯甲烷 为溶剂, 以996 mg (98%)的产率得到(R/S)-1,2,3,4-tetrahydro-2,2,4-trimethyl-7-(1,1,1-trimethylacetoxy)quinoline
    参考文献:
    名称:
    Tricyclic steroid receptor modulator compounds and methods
    摘要:
    披露了对类固醇受体具有高亲和力、高选择性调节剂的非类固醇化合物。还披露了包含这些化合物的药物组合物、使用所披露的化合物和组合物治疗需要类固醇受体激动剂或拮抗剂治疗的患者的方法,以及在制备这些化合物中有用的中间体和制备类固醇受体调节剂化合物的过程。
    公开号:
    US05696130A1
点击查看最新优质反应信息

文献信息

  • Tricyclic steroid receptor modulator compounds and methods
    申请人:Ligand Pharmaceuticals Incorporated
    公开号:US05696130A1
    公开(公告)日:1997-12-09
    Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.
    披露了对类固醇受体具有高亲和力、高选择性调节剂的非类固醇化合物。还披露了包含这些化合物的药物组合物、使用所披露的化合物和组合物治疗需要类固醇受体激动剂或拮抗剂治疗的患者的方法,以及在制备这些化合物中有用的中间体和制备类固醇受体调节剂化合物的过程。
  • Water-soluble rhodamine dye peptide conjugates
    申请人:Apptera Corporation
    公开号:US06372907B1
    公开(公告)日:2002-04-16
    The present invention provides novel, water-soluble, red-emitting fluorescent rhodamine dyes and red-emitting fluorescent energy-transfer dye pairs, as well as labeled conjugates comprising the same and methods for their use. The dyes, energy-transfer dye pairs and labeled conjugates are useful in a variety of aqueous-based applications, particularly in assays involving staining of cells, protein binding, and/or analysis of nucleic acids, such as hybridization assays and nucleic acid sequencing.
    本发明提供了新颖的水溶性、红色发射的荧光罗丹明染料和红色发射的荧光能量转移染料对,以及包括这些染料的标记共轭物和它们的使用方法。这些染料、能量转移染料对和标记共轭物在各种基于水的应用中非常有用,特别是在涉及细胞染色、蛋白质结合和/或核酸分析的试验中,比如杂交试验和核酸测序。
  • FLUORESCENT NUCLEOBASE CONJUGATES HAVING ANIONIC LINKERS
    申请人:Applera Corporation
    公开号:EP1317464B1
    公开(公告)日:2009-05-13
  • ATROPISOMERS OF ASYMMETRIC XANTHENE FLUORESCENT DYES AND METHOD OF DNA SEQUENCING AND FRAGMENT ANALYSIS
    申请人:Lee G. Linda
    公开号:US20070254298A1
    公开(公告)日:2007-11-01
    Atropisomeric energy-transfer dye compounds are disclosed. A variety of molecular biology applications utilize atropisomeric xanthene fluorescent dyes as labels for substrates such as nucleotides, nucleosides, polynucleotides, polypeptides and carbohydrates. Methods include DNA sequencing, DNA fragment analysis, PCR, SNP analysis, oligonucleotide ligation, amplification, minisequencing, and primer extension.
  • Steroid receptor modulator compounds and methods
    申请人:Ligand Pharmaceuticals Incorporated
    公开号:US05688808A1
    公开(公告)日:1997-11-18
    Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.
    披露了对类固醇受体具有高亲和力、高选择性调节剂的非类固醇化合物。还披露了包含这些化合物的药物组合物、使用所披露的化合物和组合物治疗需要类固醇受体激动剂或拮抗剂治疗的患者的方法,以及在制备这些化合物中有用的中间体和制备类固醇受体调节剂化合物的过程。
查看更多